Response n (%)

Yes

7 (87.5)

No

1 (12.5)

Need for 2nd generation hormone therapy after radiotherapy, n (%)

6 (75)

Median follow-up (months)

12.5 (5 - 93)

Median survival without 2nd line hormone therapy (months)

9 (3 - 75)

Median progression-free survival (months)

7 (2 - 75)